Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-18 4:29 pm Purchase | 2026-06-11 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Commodore Capital LP | 5,721,109 9.900% | 5,721,109 (New Position) | Filing History |
| 2026-06-03 4:39 pm Purchase | 2026-05-27 | 13G | EYEPOINT INC EYPT | Commodore Capital LP | 4,250,000 5.100% | 4,250,000 (New Position) | Filing History |
| 2026-06-02 5:31 pm Purchase | 2026-05-26 | 13G | EDITAS MEDICINE INC EDIT | Commodore Capital LP | 16,045,802 9.900% | 16,045,802 (New Position) | Filing History |
| 2026-05-28 4:20 pm Purchase | 2026-05-20 | 13G | RESEARCH ALLIANCE CORP III CL RACC | Commodore Capital LP | 500,000 5.500% | 500,000 (New Position) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Commodore Capital LP | 4,800,940 7.700% | -1,222,017 (-20.29%) | Filing History |
| 2026-05-15 4:19 pm Purchase | 2026-03-31 | 13G | PEPGEN INC PEPG | Commodore Capital LP | 4,475,000 6.500% | 930,899 (+26.27%) | Filing History |
| 2026-05-15 4:19 pm Sale | 2026-03-31 | 13G | TYRA BIOSCIENCES INC TYRA | Commodore Capital LP | 2,475,000 4.200% | -900,000 (-26.67%) | Filing History |
| 2026-05-15 4:14 pm Purchase | 2026-03-31 | 13G | PALISADE BIO INC COM P PALI | Commodore Capital LP | 12,366,776 7.200% | 2,676,111 (+27.62%) | Filing History |
| 2026-05-15 4:11 pm Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | Commodore Capital LP | 1,972,369 6.800% | 747,369 (+61.01%) | Filing History |
| 2026-05-15 4:11 pm Purchase | 2026-03-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Commodore Capital LP | 14,054,940 9.900% | 7,247,433 (+106.46%) | Filing History |
| 2026-05-15 4:07 pm Purchase | 2026-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Commodore Capital LP | 3,588,180 9.900% | 342,552 (+10.55%) | Filing History |
| 2026-05-04 4:25 pm Purchase | 2026-04-27 | 13G | RELMADA THERAPEUTICS INC P RLMD | Commodore Capital LP | 5,505,527 5.100% | 5,505,527 (New Position) | Filing History |
| 2026-04-24 4:48 pm Purchase | 2026-04-17 | 13G | JATT II ACQUISITION CORP USD O JATT | Commodore Capital LP | 500,000 6.400% | 500,000 (New Position) | Filing History |
| 2026-04-02 4:26 pm Purchase | 2026-03-26 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Commodore Capital LP | 1,950,000 9.900% | 1,820,959 (+1411.15%) | Filing History |
| 2026-03-16 4:21 pm Purchase | 2026-03-09 | 13G | AN2 THERAPEUTICS INC ANTX | Commodore Capital LP | 3,697,435 9.900% | 3,697,435 (New Position) | Filing History |
| 2026-03-11 4:06 pm Purchase | 2026-03-04 | 13G | PEPGEN INC PEPG | Commodore Capital LP | 3,544,101 5.100% | 3,544,101 (New Position) | Filing History |
| 2026-02-24 4:38 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Commodore Capital LP | 1,335,012 9.900% | 1,335,012 (New Position) | Filing History |
| 2026-02-17 4:42 pm Sale | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,802,905 1.800% | -7,405,155 (-72.54%) | Filing History |
| 2026-02-17 4:35 pm Sale | 2025-12-31 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | Commodore Capital LP | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2026-02-17 4:29 pm Sale | 2025-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Commodore Capital LP | 1,475,000 1.400% | -4,225,000 (-74.12%) | Filing History |